drugset

drugset / Trial / NCT05557448

To Evaluate the Efficacy and Safety of TYNADOTE® in the Treatment of Acetaminophen Overdose

NCT05557448 ↗

Phase 2 Recruiting 24 enrolled Sinew Pharma Inc. Taipei Veterans General Hospital, Taiwan · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the efficacy and safety of TYNADOTE® in the treatment of acetaminophen overdose

Timeline

Start: 2023-05-01
Primary completion: 2026-12
Completion: 2026-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	TYNADOTE	Unknown	200 mg	Oral

Indications